Raise capital when you can clearly see upcoming growth and need resources to service it. Tying your timeline to operational milestones, like onboarding new customers, creates genuine urgency and momentum. This drives investor FOMO and helps close deals more effectively than an arbitrary deadline.

Founders often try to fix their pricing or model when faced with inconsistent results. However, the real problem is usually a lack of volume. Sporadic outcomes are a symptom of not doing enough outreach. The solution isn't to tweak the model, but to 5x or 10x the promotional activity.

The best time to raise capital is when you don't need it. Approach early conversations with investors not to ask for money, but to listen, learn, and improve your strategy. Genuinely excited investors will offer to invest without being explicitly asked.

The best time to raise money is when your company doesn't desperately need it. Approaching investors from a position of strength gives you leverage. If you wait until you're desperate, you will be forced to accept expensive, highly dilutive capital.

Effective fundraising isn't a single event but a process. By conducting regular 'non-deal roadshows,' you build investor confidence and prove management's ability to execute on promises over time. This makes the eventual request for capital much more likely to succeed because trust has already been established.

Investors like Stacy Brown-Philpot and Aileen Lee now expect founders to demonstrate a clear, rapid path to massive scale early on. The old assumption that the next funding round would solve for scalability is gone; proof is required upfront.

While passion for helping patients is a powerful motivator, founders must learn to frame their pitch around value creation for investors. This means explicitly connecting the science and clinical benefit to the commercial market, reimbursement strategy, and ultimate financial return for their limited partners.

In capital-intensive markets like AI, capital is a competitive weapon. If fundraising feels easy, it's a signal you weren't aggressive enough. Kalanick's philosophy suggests you should have pushed for a much larger round to create a significant moat against competitors, treating capital as a strategic advantage.

For deep tech startups lacking traditional revenue metrics, the fundraising pitch should frame the market as inevitable if the technology works. This shifts the investor's bet from market validation to the team's ability to execute on a clear technical challenge, a more comfortable risk for specialized investors.